Advertisement
UK markets close in 3 hours 56 minutes
  • FTSE 100

    8,297.61
    +84.12 (+1.02%)
     
  • FTSE 250

    20,402.59
    +238.05 (+1.18%)
     
  • AIM

    777.45
    +5.92 (+0.77%)
     
  • GBP/EUR

    1.1647
    -0.0013 (-0.11%)
     
  • GBP/USD

    1.2547
    -0.0017 (-0.14%)
     
  • Bitcoin GBP

    51,017.41
    -229.45 (-0.45%)
     
  • CMC Crypto 200

    1,328.76
    -36.37 (-2.66%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CRUDE OIL

    78.15
    -0.33 (-0.42%)
     
  • GOLD FUTURES

    2,323.80
    -7.40 (-0.32%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     
  • DAX

    18,292.20
    +116.99 (+0.64%)
     
  • CAC 40

    8,026.99
    +30.35 (+0.38%)
     

Merck’s Diabetes Portfolio in 3Q17

The combined revenues of Merck's (MRK) Januvia and Janumet in 3Q17 was $1.52 billion, a 2% decline compared to $1.55 billion in 3Q16, mainly due to lower sales of Janumet.